Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020
The global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020. The global tissue diagnostics market is segmented based on products, technology, diseases, and end users. On the basis of product, the tissue diagnostics market is segmented into instruments and consumables. The instruments product segment is further subsegmented into slide-staining systems, scanners, tissue-processing systems, and other instruments. Other instruments include digital pathology systems and histology equipment like automated cover slippers, microtomes, paraffin dispensers, and slide labelers. Consumables product segment is further subsegmented into antibodies, kits, reagents, and probes.
On the basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. On the basis of diseases, the tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users.
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global tissue diagnostics market in 2015. Asia, on the other hand, is expected to register faster growth during 2015 to 2020.
The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market.
A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global tissue diagnostics market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of market players. Estimates of their tissue diagnostics product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in growth rates.
The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments expected to see rapid growth in each geographic segment. The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the tissue diagnostics market. The competitive landscape covers the growth strategies adopted by industry players over the last four years. It also includes an analysis of industry developments.
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
The report provides insights on the following:
Product Development: Product portfolios of the top players in the tissue diagnostics market.
Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the tissue diagnostics market.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various tissue diagnostics products across geographies.